Rifampin Capsule
NDC Package 68180-658-01
Package Information
Rifampin capsules is a medication a rifamycin antibiotic used to prevent and treat tuberculosis and other infections. This formulation utilizes a capsule delivery system. Marketed by Lupin Pharmaceuticals, Inc., this product is identified by NDC 68180-658 and is authorized under FDA application ANDA090034.
Identification & Billing
- RxCUI: 198201 - rifAMPin 150 MG Oral Capsule
- RxCUI: 198201 - rifampin 150 MG Oral Capsule
- RxCUI: 198202 - rifAMPin 300 MG Oral Capsule
- RxCUI: 198202 - rifampin 300 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68180 - Lupin Pharmaceuticals, Inc.
- 68180-658 - Rifampin
- 68180-658-01 - 60 CAPSULE in 1 BOTTLE
- 68180-658 - Rifampin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (68180-658). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68180-658-01 identifies a specific commercial package of 60 capsule in 1 bottle of Rifampin, a human prescription drug labeled by Lupin Pharmaceuticals, Inc.. This capsule is formulated for oral use and contains rifampin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Lupin Pharmaceuticals, Inc. on January 08, 2014. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is a rifamycin antibiotic used to prevent and treat tuberculosis and other infections. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.
How is this Lupin Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68180065801. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.